News
The studio head at Cloud Chamber, the 2K studio currently developing the next Bioshock, has been "ousted" in the latest blow ...
Ever clicked a meme coin and felt like you just adopted a digital raccoon instead of an investment? Yeah, welcome to the wild ...
TOXBOX, a Horizon Europe funded research initiative, has successfully concluded the first 18 months of its four-year mission to revolutionize chemical safety testing. With 16 partners from 10 ...
The crypto market is heating up once again, and though much of the attention is paid to Ethereum, one less popular rival is also stirring up things by the name of Ozak AI. Ozak AI is in the presale ...
3d
Calgary Herald on MSNAquatic facility at Southland Leisure Centre to close for three months for electrical repairsThe Southland Leisure Centre’s aquatic facility is next in line for a deep-dive of electrical repairs and lifecycle ...
With crypto markets about to go haywire again in a raging bull run, whales have already secured themselves in strategic positions with viable assets that have t ...
Dr Vere Ross Gillespie Senior Aquatic Ecologist and Mining Sector Lead at NatureMetrics details why habitat insights and ...
How a person grows and ages is the result of a complex interplay between the body and external stimuli. The respective hormone mix determines life milestones such as reproduction, pregnancy, ...
Mayor Deegan proposes $687 million list of capital improvement projects that includes the stadium, parks, roads, UF trauma ...
OncoZenge AB (publ) ("OncoZenge" or "the Company") today announced a comprehensive market and strategy update after successfully securing full funding for its BupiZenge™ Phase 3 clinical trial aimed ...
Q2 2025 Earnings Call Transcript July 31, 2025 Ferrari N.V. beats earnings expectations. Reported EPS is $2.7, expectations were $2.57. Operator: Good day, and thank you for standing by. Welcome to ...
OncoZenge AB (publ) ("OncoZenge" or "the Company") today announced a comprehensive market and strategy update after successfully securing full funding for its BupiZenge Phase 3 clinical trial aimed at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results